PODCAST

Ophthalmology

ReachMD

science & medicine medicine

All Episodes

00:00:00

Underlying Mediators of Immune Dysregulation in TED

Ophthalmology ·

2024/09/30

Guest: Selina McGee, OD, FAAO Guest: Terry J. Smith, MD Thyroid eye disease (TED) is a relatively rare disease that is challenging to diagnose and has limited treatment options. TED may be overlooked by clinicians due to the wide range of clinical manifestations, ranging from dry eye disease to diplopia, proptosis, eyelid retraction, and sight-threatening optic neuropathy. Although TED is often associated with thyroid disorders such as Graves’ disease, cases without typical

00:00:00

Diagnostic Challenges of TED: What Endocrinologists...

Ophthalmology ·

2024/09/30

Guest: Fatemeh Rajaii, MD, PhD Guest: Terry J. Smith, MD Thyroid eye disease (TED) is a relatively rare disease that is challenging to diagnose and has limited treatment options. TED may be overlooked by clinicians due to the wide range of clinical manifestations, ranging from dry eye disease to diplopia, proptosis, eyelid retraction, and sight-threatening optic neuropathy. Although TED is often associated with thyroid disorders such as Graves’ disease, cases without typical

00:00:00

Diagnostic Challenges of TED: What General Eye Care...

Ophthalmology ·

2024/09/30

Host: Prem S. Subramanian, MD, PhD Guest: Selina McGee, OD, FAAO Thyroid eye disease (TED) is a relatively rare disease that is challenging to diagnose and has limited treatment options. TED may be overlooked by clinicians due to the wide range of clinical manifestations, ranging from dry eye disease to diplopia, proptosis, eyelid retraction, and sight-threatening optic neuropathy. Although TED is often associated with thyroid disorders such as Graves’ disease, cases without

00:00:00

Diagnostic Challenges of TED: What Eye Care...

Ophthalmology ·

2024/09/30

Host: Prem S. Subramanian, MD, PhD Guest: Fatemeh Rajaii, MD, PhD Thyroid eye disease (TED) is a relatively rare disease that is challenging to diagnose and has limited treatment options. TED may be overlooked by clinicians due to the wide range of clinical manifestations, ranging from dry eye disease to diplopia, proptosis, eyelid retraction, and sight-threatening optic neuropathy. Although TED is often associated with thyroid disorders such as Graves’ disease, cases without

00:00:00

TED: Current Treatments, Current Challenges

Ophthalmology ·

2024/09/30

Host: Prem S. Subramanian, MD, PhD Guest: Terry J. Smith, MD Thyroid eye disease (TED) is a relatively rare disease that is challenging to diagnose and has limited treatment options. TED may be overlooked by clinicians due to the wide range of clinical manifestations, ranging from dry eye disease to diplopia, proptosis, eyelid retraction, and sight-threatening optic neuropathy. Although TED is often associated with thyroid disorders such as Graves’ disease, cases without typical

00:00:00

The Future of TED

Ophthalmology ·

2024/09/30

Guest: Fatemeh Rajaii, MD, PhD Guest: Selina McGee, OD, FAAO Thyroid eye disease (TED) is a relatively rare disease that is challenging to diagnose and has limited treatment options. TED may be overlooked by clinicians due to the wide range of clinical manifestations, ranging from dry eye disease to diplopia, proptosis, eyelid retraction, and sight-threatening optic neuropathy. Although TED is often associated with thyroid disorders such as Graves’ disease, cases without typical

00:00:00

ARVO Recap: What’s New in TED

Ophthalmology ·

2024/09/30

Guest: Fatemeh Rajaii, MD, PhD Thyroid eye disease (TED) is a relatively rare disease that is challenging to diagnose and has limited treatment options. TED may be overlooked by clinicians due to the wide range of clinical manifestations, ranging from dry eye disease to diplopia, proptosis, eyelid retraction, and sight-threatening optic neuropathy. Although TED is often associated with thyroid disorders such as Graves’ disease, cases without typical clinical signs or hyperthyroidism

00:00:00

TED: Clinical Trials Spotlight

Ophthalmology ·

2024/09/30

Host: Prem S. Subramanian, MD, PhD Thyroid eye disease (TED) is a relatively rare disease that is challenging to diagnose and has limited treatment options. TED may be overlooked by clinicians due to the wide range of clinical manifestations, ranging from dry eye disease to diplopia, proptosis, eyelid retraction, and sight-threatening optic neuropathy. Although TED is often associated with thyroid disorders such as Graves’ disease, cases without typical clinical signs or

00:00:00

The Burden of TED

Ophthalmology ·

2024/09/30

Guest: Terry J. Smith, MD Guest: Selina McGee, OD, FAAO Thyroid eye disease (TED) is a relatively rare disease that is challenging to diagnose and has limited treatment options. TED may be overlooked by clinicians due to the wide range of clinical manifestations, ranging from dry eye disease to diplopia, proptosis, eyelid retraction, and sight-threatening optic neuropathy. Although TED is often associated with thyroid disorders such as Graves’ disease, cases without typical

00:00:00

Are Two Pathways Better Than One? Experts Discuss the...

Ophthalmology ·

2024/05/06

Host: Arshad M. Khanani, MD, MA Guest: Karl Csaky, MD, PhD Guest: Christina Y. Weng, MD, MBA, FASRS Anti-vascular endothelial growth factor (VEGF) therapy acts on only 1 of the multiple pathways involved in the pathophysiology of retinal vascular diseases. Dual inhibition therapy that acts on 2 pathways—VEGF-A and angiopoietin-2 (Ang-2)—is now available. Are 2 pathways better than 1? Find out in this engaging roundtable-style eye care forum, which will demonstrate direct

00:00:00

GET REAL: A Guide to Evolving Treatment of nAMD and...

Ophthalmology ·

2024/04/11

Host: Arshad M. Khanani, MD, MA Guest: Theodore Leng, MD, MS Let’s get real. Clinical trial data can be difficult to apply to retina practices. Patient populations are often limited, and injection schedules are strictly enforced in clinical trial settings. Fortunately, real-world evidence based on large registry data are amassing to shed light on current treatment practices and their effects on patients with neovascular age-related macular degeneration (nAMD) and diabetic macular

11 results

Ophthalmology

All Episodes

Similar Podcasts

Eye On The Sky

Vermont Public

Cienciaes.com

cienciaes.com

This Week in Virology

Vincent Racaniello

Hablando con Científicos - Cienciaes.com

cienciaes.com

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast

Pharmacy Joe